These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 546346)

  • 1. [Effect of piperazine sultosylate (A-585) on hypertriglyceridemia induced by ethanol in man].
    Rodríguez L; Parés S; Laporte J; Roser R; Esteve J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):235-7. PubMed ID: 546346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypolipemic activity of piperazine sultosylate (A-585) in the rat and chicken].
    Rodríguez L; Roser R; Palacios G; Sagarra R; Esteve A
    Arch Farmacol Toxicol; 1979 Dec; 5(3):272-4. PubMed ID: 546353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of sigetin on the concentration of triglycerides and cholesterol in rat blood and liver].
    Svergun VT
    Biull Eksp Biol Med; 1979 Feb; 87(2):151-3. PubMed ID: 420935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of piperazine sultosylate in the hyperlipidemias].
    Casellas Bernat A; Ribas Grau M; Casellas Bernat G; Riera de Barcia L; Alou Llado M; Solivellas Antich S
    Rev Clin Esp; 1981 Apr; 161(1):5-8. PubMed ID: 7255818
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxicologic study of piperazine sultosylate (A-585)].
    Rodríguez L; Demestre I; Sagarra R; Laporte J; Esteve A
    Arch Farmacol Toxicol; 1979 Dec; 5(3):281-3. PubMed ID: 546355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of simfibrate on post-heparin lipoprotein lipase].
    Cavallini L; Lucchetti G; Marchi S; Guglielmini R
    Clin Ter; 1980 Jan; 92(1):25-31. PubMed ID: 7004746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
    Elsair J; Marquie G; Drif M; Khelfat K; Benouniche N; Tabet Aoul M; Tabet Aoul FS; Iklef F; Ghouini A
    C R Seances Soc Biol Fil; 1982; 176(2):140-5. PubMed ID: 6212098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M; Nowicka G; Szostak WB; Kłosiewicz-Latoszek L
    Kardiol Pol; 1982; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effect of halofenate on serum lipids.
    Aronow WS; Vangrow J; Pagano J; Khemka M; Vawter M; Papageorge's NP
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):897-903. PubMed ID: 4214664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinico-pharmacological studies on the lipid lowering effect of EMO 100 and clofibrate].
    Leopold G; Simane Z; Stoll KD; Breuer J
    Med Welt; 1975 Aug; 6(35):1542-4. PubMed ID: 1177741
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
    Wolfe BM; Kane JP; Havel RJ; Brewster HP
    J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
    Schulze F; Glos S; Petruschka D; Altenburg C; Maas R; Benndorf R; Schwedhelm E; Beil U; Böger RH
    Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
    Davies JE; Kellett DN
    Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
    Jarillo MD; Coca MC; Díaz Rubio C; Bello I; Gutiérrez-Millet V; Ruilope LM; Rodicio JL; Alvarez Ude F
    Med Clin (Barc); 1980 Nov; 75(8):334-7. PubMed ID: 7442334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
    Rodney G; Uhlendorf P; Maxwell RE
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.